Edition:
United States

Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

6.94USD
3:14pm EDT
Change (% chg)

$-0.01 (-0.14%)
Prev Close
$6.95
Open
$6.91
Day's High
$7.03
Day's Low
$6.88
Volume
121,087
Avg. Vol
434,626
52-wk High
$8.09
52-wk Low
$1.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Dec 3.51 -0.176
FY 2017 Sep '17 8.71 -0.144
Jun '17 9.34 -0.074
Mar '17 8.99 -0.081
Dec 4.37 -0.169
FY 2016 Sep '16 0.03 -0.342
Jun '16 0.04 -0.324
Mar '16 0.04 -0.348
Dec 0.04 -0.324
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 5 1.85 3.51 0.62 0.62
Quarter Ending Jun-18 5 1.85 3.51 0.62 0.62
Year Ending Sep-18 6 10.04 15.00 5.39 12.60
Year Ending Sep-19 5 41.18 164.00 0.00 2.82
Earnings (per share)
Quarter Ending Mar-18 6 -0.19 -0.16 -0.21 -0.19
Quarter Ending Jun-18 6 -0.19 -0.16 -0.21 -0.21
Year Ending Sep-18 6 -0.74 -0.62 -0.85 -0.56
Year Ending Sep-19 5 -0.46 0.90 -1.01 -0.54
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 185.16 33.25
P/E High - Last 5 Yrs. -- 283.72 45.98
P/E Low - Last 5 Yrs. -- 95.28 24.86
Beta 2.36 0.75 0.80
Price to Sales (TTM) 19.91 137.70 7.20
Price to Book (MRQ) 7.36 19.28 5.06
Price to Tangible Book (MRQ) 12.00 24.18 6.69
Price to Cash Flow (TTM) -- 120.88 25.20
% Owned Institutions 26.96 11.42 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.76
Dividend 5 Year Growth Rate -- 1.94 3.96
Payout Ratio(TTM) -- 9.17 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -19.60 81.55 8.73
Sales (TTM) vs TTM 1 Yr. Ago 581.95 97.79 11.30
Sales - 5 Yr. Growth Rate 192.43 33.72 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -4.26 -66.22 22.52
EPS (TTM) vs TTM 1 Yr. Ago 59.89 -- --
EPS - 5 Yr. Growth Rate -- 47.04 10.26
Capital Spending - 5 Yr. Growth Rate 75.20 45.24 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.53
Current Ratio (MRQ) 3.87 6.01 3.61
LT Debt to Equity (MRQ) 3.21 23.49 11.52
Total Debt to Equity (MRQ) 3.51 25.92 14.21
Interest Coverage (TTM) -- -189.88 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 34.63 54.09
Gross Margin - 5 Yr. Avg. -- 55.35 52.20
EBITD Margin (TTM) -102.32 -- --
EBITD - 5 Yr. Avg -844.29 -153.57 15.86
Operating Margin (TTM) -117.53 -573.06 3.97
Operating Margin - 5 Yr. Avg. -902.65 -165.53 11.17
Pre-Tax Margin (TTM) -116.16 -545.71 4.62
Pre-Tax Margin - 5 Yr. Avg. -920.80 -172.26 11.49
Net Profit Margin (TTM) -116.17 -534.59 1.24
Net Profit Margin - 5 Yr. Avg. -920.83 -172.04 7.83
Effective Tax Rate (TTM) -- -0.67 31.24
Effective Tax Rate - 5 Yr. Avg. -- 18.14 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 328,517 23,627,894 806,826,037
Net Income/Employee (TTM) -381,646 954,925 94,789,739
Receivable Turnover (TTM) 291.07 6.54 5.54
Inventory Turnover (TTM) -- 2.39 3.44
Asset Turnover (TTM) 0.26 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -30.53 -0.73 10.47
Return on Assets - 5 Yr. Avg. -55.18 0.66 11.49
Return on Investment (TTM) -38.82 -0.71 13.13
Return on Investment - 5 Yr. Avg. -63.36 4.08 14.88
Return on Equity (TTM) -42.12 -2.76 14.96
Return on Equity - 5 Yr. Avg. -66.85 -0.32 16.18
  1 Year 3 Year 5 Year
Sales % 19,736.87 464.07 192.43
EPS (TTM) % 65.24 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Arrowhead Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -1.27 99 9
13 Week 21.50 26.24 99 74
26 Week 73.75 65.30 99 88
52 Week 360.26 299.60 99 78
YTD 88.86 87.49 99 88
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 26.96%
# of Holders: 96
Total Shares Held: 23,401,240
3 Mo. Net Change: 5,102
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 4
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.